Labshake search
Citations for R&D Systems :
1 - 50 of 2638 citations for Chitinase 3 Like Protein 2 CHI3L2 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2021Quote: ... and Human chitinase 3-like 1 (YKL-40) were purchased from R&D Systems. Bovine serum albumin was purchased from Sigma Aldrich ...
-
bioRxiv - Pathology 2020Quote: ... goat polyclonal anti YM1/Chitinase-3 like 3 (R&D systems, Cat. No. AF2446, 1:400 dilution). Antigen retrieval of HIER2 (EDTA ...
-
bioRxiv - Genomics 2020Quote: ... YKL-40 levels were measured using a human chitinase-3 quantikine ELISA kit (R&D systems, Inc, Minneapolis, MN 20). To reduce the skewness of phenotype distributions ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Developmental Biology 2023Quote: ... Chordin like-1 recombinant protein 0.4 μg/mL (R&D Systems 1808-NR-050/CF). For 2-DOG wash-out experiments ...
-
bioRxiv - Cell Biology 2023Quote: ... Recombinant mouse Follistatin-like 1 protein (rFSTL1, R&D systems, MN, #1738-FN, 100ng/ml) was added into the culture media 24 h after plating cells and incubated for 24 hrs ...
-
bioRxiv - Microbiology 2023Quote: ... Human Airway Trypsin-like protease (R&D Systems). For each experiment ...
-
bioRxiv - Immunology 2022Quote: ... IL4 (10 ng/mL, M2-like, R&D Systems) or medium (M0 macrophages) ...
-
bioRxiv - Cell Biology 2020Quote: ... 832/13 cells were starved for 2 h, and treated with insulin-like growth factor 1 (IGF-1, NIH repository) or hepatocyte growth factor (HGF, R&D Systems) for various times.
-
bioRxiv - Microbiology 2023Quote: ... suum were incubated with or without recombinant acidic mammalian chitinase (AMCase, 9859-GH-050, R&D systems, Minneapolis, MN) at 4 μg/ml ...
-
bioRxiv - Developmental Biology 2023Quote: ... Subsequently cell clusters were differentiated into β-like cells by exposure to the appropriate media as previously published.29 All recombinant proteins were purchased from R&D System unless otherwise stated (see Supplementary Table 3).
-
bioRxiv - Immunology 2023Quote: ... Sections were incubated overnight with unconjugated goat anti-mouse/rat CD47 N-terminal IgV-like extracellular domain antibody (R&D Systems), biotin-conjugated anti-mouse CD55 REAfinity antibody (clone REA300 ...
-
bioRxiv - Microbiology 2021Quote: ... bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% FBS in the presence of FMS-like tyrosine kinase 3 ligand (Flt3L) (100 ng/ml, R&D Systems, Cat# 308-FK) for 7-9 days ...
-
bioRxiv - Neuroscience 2022Quote: ... and insulin-like growth factor-1 (IGF-1, R&D systems) were supplemented to the media changes for 10 days ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Immunology 2023Quote: ... was pre-incubated with either 10 µl biotinylated SARS-CoV-2 spike protein (3 nM final concentration; R&D Systems cat# BT10549), or with 10 µl biotinylated irrelevant antigen (3 nM final concentration ...
-
bioRxiv - Immunology 2019Quote: ... and macrophage inflammatory protein-2 (MIP-2) (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2020Quote: ... and the mouse chemoattractant macrophage-inflammatory protein-2 (MIP-2, R&D Systems). Migration of cells was evaluated by trypan blue exclusion following incubation.
-
bioRxiv - Immunology 2021Quote: ... or rSARS-CoV-2 spike protein (R&D Systems). To detect total IgG or IgA expressing B cells ...
-
bioRxiv - Developmental Biology 2022Quote: ... we used a SMAD2/3 antibody (R&D systems, AF3797) in 2X10^6 hESCs that were treated with Activin for 2 h or 24 h with or without Wnt priming ...
-
bioRxiv - Microbiology 2024Quote: ... Cells were then stained for 30min on ice with Alexa-Fluor-488-conjugated mouse monoclonal antibody (mAb) directed against the SARS-CoV-2 spike protein (R&D systems; clone #1035206 ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Developmental Biology 2021Quote: ... and goat anti-delta/notch-like EGF repeat containing (DNER, 1:1000, AF2264, R&D Systems).
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Microbiology 2019Quote: ... or FGF-2 protein levels using ELISA (R&D systems). The LDH release was calculated as described previously (83).
-
bioRxiv - Immunology 2023Quote: ... Then biotinylated Spike proteins (WA-2, 2P, R&D systems) were subsequently captured to a level of 3-500RU by the neutravidin ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Microbiology 2019Quote: ... and lipocalin-2 (Lcn-2) protein was assayed in Mouse Lipocalin-2/NGAL DuoSet ELISA (R&D Systems, Minneapolis, MN, USA). At the end of DSS treatment ...
-
bioRxiv - Cell Biology 2021Quote: ... This antibody (clone #P3H9-2; R&D Systems) has been demonstrated to detect antigen in a variety of epithelia and has been shown to inhibit cell proliferation of both rat and human epithelial cells (32) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Immunology 2023Quote: ... human/mouse caspase-3 antibody polyclonal goat IgG (R&D systems) for HCT116 ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Neuroscience 2021Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Neuroscience 2020Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...
-
bioRxiv - Immunology 2022Quote: ... mouse anti-Dectin-2 antibody (R&D Systems, MAB1525) was preincubated with the Dectin-2-Fc fusion protein at a concentration of 50 mg/ml for 30 minutes prior to adding the mixture to FLPs.
-
bioRxiv - Microbiology 2021Quote: ... Primary antibodies for cleaved caspase-3 (catalog no. MAB835; R&D Systems) and polyclonal rabbit anti-N505 [55] were used at a concentration of 1:800 and 1:1000 respectively ...
-
bioRxiv - Immunology 2022Quote: ... Primary antibody against CD58 (CD58/LFA-3 goat polyclonal R&D system,) was used with a concentration of 1:100 (2 μg/ml ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Cell Biology 2022Quote: ... commercial Sigma-1 R antibody to 3 µg/ml (MAB1076, R&D systems) chicken Calreticulin (Abcam ...
-
bioRxiv - Microbiology 2023Quote: ... SARS-CoV-2 Spike S2 Subunit Antibody (R&D systems), IRDye® 800CW Goat anti-Human IgG (H + L) ...
-
bioRxiv - Microbiology 2023Quote: ... Primary anti-human ACE-2 antibody (#AF933, R&D systems) or isotype-matched antibody (#AB-108-C ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Microbiology 2021Quote: ... Cleaved caspase-3 was immunostained by incubating HAE with a primary human cleaved caspase-3 (Asp175) antibody (catalog no. MAB835; R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant human IL-2 protein was purchased from R&D Systems (Minneapolis, MN). Recombinant mouse Flt3 ligand (Flt3L ...